Topics that will be discussed during CT-Cann2023

• Phytocannabinoid study – strains, chemovars, entourage and molecules
• Pharamacokinetics and pharmacodynamics of cannabinoids
• How can we predict the response to cannabinoid treatment?
• Clinical cannabinoid therapy across medical specialties such as Pain, Gastroenterology, Palliative Care, Psychiatry and Neurology
• New and emerging designs for cannabis clinical trials
• Clinical Registries from around the globe – what can we learn?
• How to interpret clinical, observational and epidemiological studies: findings, interpretations, applicability
• Regulatory, licensing, and legal considerations – effects on clinical availability and industry development
• Cannabinoid trial best conduct including GCP and site training
• Assessing safety and adverse events of cannabinoid medications
• National and international guidelines
• Where is the industry heading? A discussion with leaders in the field
• Translating Current Evidence to Clinical Practice – meet the expert roundtables, open Q&A and practical tools for prescribers